Top compounds associated with response to BHLHB9


Feature Type Standardized
Nominal ANOVA
mRNA Sorafenib CCLE pan-cancer AAC 0.017 0.7
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA T0901317 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.018 0.7
mRNA RITA CTRPv2 pan-cancer AAC -0.013 0.7
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.017 0.7
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC 0.026 0.7
Download CSV